Ranked #1 Children's Hospital by U.S. News & World Report
MyPatients provides referring primary care providers with secure access to their patients’ information.
Boston Children's has launched the world's 1st program dedicated to offering hand transplants to children who qualify.
Innovation insider is a semi-monthly e-newsletter analyzes innovations at Boston Children’s, other academic medical centers and from industry.
Read the latest blog by a Boston Children's doctor, clinician or staff member.
Support the hospital with a donation that helps kids get the care they need.
Premature babies often need to be placed on ventilators, but these life-saving machines can sometimes damage their delicate lungs. In recent experiments in newborn mice whose lungs were injured, stem cells taken from the bone marrow were injected into the bloodstream and found their way to the lungs. Once there, the stem cells ensured proper growth and development. Surprisingly, even the fluid in which the cells were grown was able to protect the lungs – in fact, better than the stem cells themselves.
Stella Kourembanas, MD, Chief of Boston Children’s Division of Newborn Medicine, believes this fluid, or certain proteins her lab has isolated within it, may become a future treatment to prevent preemies from developing chronic lung disease. She would also like to conduct follow-up experiments that use stem cells taken from the umbilical cord, which can be obtained in a less invasive manner than bone marrow cells.
For more information on this article, click here.
Research was published in the December 1 issue of American Journal of Respiratory and Critical Care Medicine.
The future of pediatrics will be forged by thinking differently, breaking paradigms and joining together in a shared vision of tackling the toughest challenges before us.”